---

---

tags : Presentation    crawled time : 20:00   

save search

---

BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
BCAB | $2.35 4.91% 4.68% 390K |

| Email alert Add to watchlist
presentation meeting

---

IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
IOBT | $1.455 -1.02% -1.03% 57K |

| Email alert Add to watchlist
biotech presentation for meeting

---

Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
CRBP | $35.5 -5.94% -6.37% 220K |

Health Technology

| Email alert Add to watchlist
presentation asco pharmaceuticals for meeting

---

Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Just crawled : 20:00) - globenewswire.com
POAI | $1.34 3.88% 3.73% 24K |

Health Technology

| Email alert Add to watchlist
presentation for meeting

---

Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
FATE | News | $4.3 -5.29% -5.58% 2M |

Health Technology

| -5.02% | O: 0.21% H: 4.8% C: -5.22%
ft819 presentation for meeting therapeutics

---

MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
MGTX | $4.87 -1.22% -1.23% 110K |

Health Technology

| -1.6% | O: -1.0% H: 3.23% C: 2.62%
conference presentation

---

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
LUMO | $2.795 -0.18% -0.18% 46K |

Health Technology

| 11.11% | O: 5.16% H: 6.79% C: -2.26%
pharma presentation for medical

---

Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024
Published: 2024-04-09 (Crawled : 20:00) - prnewswire.com
FUSN | $21.4 -0.09% -0.09% 270K |

Health Technology

| 0.19% | O: -0.19% H: 0.28% C: 0.09%
fpi-2265 presentation pharmaceuticals meeting trial

---

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
STTK | $9.87 4.0% 3.85% 230K |

Health Technology

| 5.44% | O: -1.11% H: 9.78% C: 9.66%
association presentation cancer research preclinical for meeting

---

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
CADL | $6.03 2.03% 1.99% 660K |

| Email alert Add to watchlist
can-3110 drug presentation update trial therapeutics glioblastoma

---

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-03-28 (Crawled : 20:00) - prnewswire.com
HRTX M | $2.66 -5.0% -5.26% 2.2M |

Health Technology

| Email alert Add to watchlist
conference presentation therapeutics

---

Biond Biologics Announces Presentation of BND-35, a Novel Anti-ILT3 Antibody for Remodeling the Tumor Microenvironment, at the American Association for Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.51% | O: 1.93% H: 0.0% C: 0.0%
bnd-35 antibody association presentation cancer tumor research meeting

---

Inventiva announces the schedule of publication and presentation of its 2023 Full-Year Financial Results
Published: 2024-03-22 (Crawled : 20:00) - globenewswire.com
IVA | $3.28 -0.3% -0.3% 13K |

Health Technology

| Email alert Add to watchlist
presentation publication financial results

---

PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
Published: 2024-03-18 (Crawled : 20:00) - globenewswire.com
PMVP | $1.69 -6.37% -6.8% 200K |

Commercial Services

| 7.78% | O: 5.99% H: 1.13% C: -4.52%
presentation cancer pharmaceuticals meeting advanced

---

Euroseas Ltd. to Participate at Capital Link’s Corporate Presentation Series
Published: 2024-01-16 (Crawled : 20:00) - globenewswire.com
ESEA | $33.005 -3.72% -3.86% 35K |

Transportation

| -4.03% | O: -0.14% H: 2.69% C: 2.3%
presentation series

---

Viridian Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-04 (Crawled : 20:00) - biospace.com/
VRDN | $13.04 -8.49% -9.28% 770K |

Health Care and Social Assistan...

| -33.75% | O: 0.19% H: 3.53% C: 2.09%
conference presentation therapeutics

---

Hologic to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-02 (Crawled : 20:00) - biospace.com/
HOLX | $76.71 -0.62% -0.63% 910K |

Health Technology

| 8.03% | O: -0.57% H: 2.21% C: 2.0%
conference presentation

---

IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023
Published: 2023-12-11 (Crawled : 20:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -0.31% | O: 0.43% H: 0.0% C: 0.0%
fucaso presentation

---

Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023
Published: 2023-11-13 (Crawled : 20:00) - prnewswire.com
LPCN | $4.51 -6.04% -6.43% 66K |

Health Technology

| 72.66% | O: -2.52% H: 6.27% C: -0.92%
meeting liver presentation results phase 2

---

Arrowroot Acquisition Files Investor Presentation on iLearningEngines Deal
Published: 2023-11-07 (Crawled : 20:00) - spacfeed.com
VSAC | $11.13 0.0% 24K |

n/a

| Email alert Add to watchlist
presentation acquisition deal

---

Gainers vs Losers

65%

35%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 210M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---